期刊文献+

性激素对雄性非酒精性脂肪性肝炎小鼠的影响研究

Influence of Sex Hormone on Non-alcoholic Steatohepatitis in Male Mice
下载PDF
导出
摘要 目的探讨性激素对蛋氨酸-胆碱缺乏(MCD)饮食诱导非酒精性脂肪性肝炎(NASH)小鼠的影响。方法选用14周龄C57BL/6雄性小鼠50只,采用随机数字表法分为对照组、MCD组、睾丸切除组、睾丸切除+雄激素组、睾丸切除+雌激素组5组,每组10只。对照组和MCD组小鼠行假手术,睾丸切除组、睾丸切除+雄激素组、睾丸切除+雌激素组小鼠行睾丸切除术,恢复2 d后,对照组小鼠饲喂MCD对照饮食,其余4组小鼠饲喂MCD饮食,建立MCD饮食诱导C57BL/6雄性NASH小鼠模型;性别干预:睾丸切除+雄激素组小鼠皮下注射丙酸睾酮,睾丸切除+雌激素组小鼠皮下注射苯甲酸雌二醇。比较各组小鼠非酒精性脂肪性肝病活动度评分(NAS)及血清睾酮、雌二醇、ALT、AST水平。结果 MCD组、睾丸切除组、睾丸切除+雄激素组、睾丸切除+雌激素组NAS总分秩均值均大于对照组(P<0.05),睾丸切除组、睾丸切除+雌激素组NAS总分秩均值均小于MCD组(P<0.05),睾丸切除+雌激素组NAS总分秩均值均小于睾丸切除组、睾丸切除+雄激素组(P<0.05)。睾丸切除组和睾丸切除+雌激素组小鼠血清睾酮水平均低于对照组、MCD组、睾丸切除+雄激素组(P<0.05),睾丸切除+雌激素组小鼠血清雌二醇水平均高于对照组、MCD组、睾丸切除组、睾丸切除+雄激素组(P<0.05);MCD组、睾丸切除组、睾丸切除+雄激素组、睾丸切除+雌激素组小鼠血清ALT、AST水平均高于对照组(P<0.05),睾丸切除组小鼠血清ALT、AST水平均低于MCD组(P<0.05),睾丸切除+雌激素组小鼠血清ALT、AST水平均低于MCD组、睾丸切除组、睾丸切除+雄激素组(P<0.05)。结论在MCD饮食诱导C57BL/6雄性NASH小鼠模型中,雌激素可减轻NASH病情严重程度,而雄激素的作用还有待商榷。 Objective To study the influence of sex hormone on non - alcoholic steatohepatitis (NASH) induced by methionine and choline -deficient (MCD) diet. Methods 50 C57BL/6 male mice of 14 weeks were selected and randomly di- vided into control group, MCD group, orchideetomy group, orchideetomy + male hormone group and orehideetomy + female hor- mone group, with each group 10 mice. The control group and MCD group were given sham operation, while the other three groups were given orehideetomy. Two days after the operation, the control group was given MCD control diet, while the other four groups were given MCD diet to establish C57BL/6 NASH model. The orehideetomy + male hormone group was given subcutaneous injec- tion of testosterone propionate, while the orchideetomy + female hormone group was given subcutaneous injection of estradiol ben- zoate. The NAS, serum testosterone, estradiol, ALT and AST levels were compared between the groups. Results The NAS of the control group was lower than the other four groups ( P 〈 0. 05 ), and the NAS in orchidectomy group and orchidectomy + female hormone group was lower than the MCD group ( P 〈 0. 05 ), and the NAS in orchidectomy + female hormone group was lower than the orchidectomy group and orchidectomy + male hormone group ( P 〈 0. 05 ) . The testosterone level in orchidectomy group and orchidectomy + female hormone group was lower than the control group, MCD group and orchidectomy + male hormone group ( P 〈 0. 05 ), and the estradiol level in orchidectomy + female hormone group was higher than the other four groups ( P 〈 0. 05 ) . The ALT and AST levels of the control group were lower than the other four groups (P 〈 0. 05 ) . The ALT and AST levels of the orchidectomy group were lower than the MCD group ( P 〈 0. 05 ), and the ALT and AST levels of the orchidectomy + female hormone group were lower than the MCD group, orchidectomy group and orchidectomy + male hormone group ( P 〈 0. 05 ). Conclusion The female hormone can alleviate NASH induced by MCD diet in C57BL/6 male mice, while the effect of male hor- mone remains to be studied.
出处 《中国全科医学》 CAS CSCD 北大核心 2014年第12期1370-1373,共4页 Chinese General Practice
关键词 雄激素类 雌激素类 非酒精性脂肪性肝炎 Androgens Estrogens Non - alcoholic steatohepatitis
  • 相关文献

参考文献14

  • 1Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies [J]. J Hepatol, 2005, 42 (1) : 132 -138.
  • 2Kashi MR, Torres DM, Harrison SA. Current and emerging therapies in nonalcoholic fatty liver disease [ J]. Semin Liver Dis, 2008, 28 (4) : 396 - 406.
  • 3Hashimoto E, Yatsuji S, Kaneda H, et al. The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease [J]. Hepatol Res, 2005, 33 (2): 72-76.
  • 4Sanyal A J, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C [J]. Hepatology, 2006, 43 (4): 682-689.
  • 5Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH [J]. J Gastroenterol, 2011, 46 (Suppl 1) : 63 - 69.
  • 6Kirsch R, Clarkson V, Shephard EG, et al. Rodent nutritional model of non - alcoholic steatohepatitis: species, strain and sex difference studies [J]. J Gastroenterol Hepatol, 2003, 18 (11) : 1272 - 1282.
  • 7Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease [ J ]. Hepatology, 2005, 41 (6): 1313-1321.
  • 8Tian GX, Sun Y, Pang C J, et al. Oestradiol is a protective factor for non - alcoholic fatty liver disease in healthy men [ J ]. Obes Rev, 2012, 13 (4): 381-387.
  • 9Mu Y, She R, Zhang H, et al. Effects of estrogen and androgen dep- rivation on the progression of non - alcoholic steatohepatitis (NASH) in male Sprague-Dawley rats [J]. Hepatol Res, 2009, 39 (9): 910 - 920.
  • 10Zhang H, Liu Y, Wang L, et al. Differential effects of estrogen/an- drogen on the prevention of nonalcoholic fatty liver disease in the male rat [J]. J Lipid Res, 2013, 54 (2): 345-357.

二级参考文献8

  • 1Bedogni G, Bellentani S. Fatty liver: how frequent is it and why? [J]. Ann Hepatol, 2004, 3: 63-65.
  • 2Caldwell S H, Chang C Y, Nakamoto R K, et al.Mitochondria in nonalcoholic fatty liver disease [J]. Clin Liver Dis, 2004, 8: 595-617.
  • 3Sanyal A J. AGA technical review on nonalcoholic fatty liver disease[J]. Gastroenterology, 2002, 123:1705-1725.
  • 4Hewitt K, Jones M E, Simpson E R. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse[J]. Endocrinology, 2004, 145:1842-1848.
  • 5Couse S C, Bunch D O, Sat M, et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta[J]. Science, 1999, 286: 2328-2331.
  • 6Dieudonne M N, Pecquery R, Boumediene A, et al. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids [J]. Am J Physiol, 1998, 274: C1645-1652.
  • 7Boisvert W, Black A, Curtiss L. ApoAl reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages [J]. Arterioscl Throm Vas, 1999, 19: 525-530.
  • 8Nemoto Y, Saibara T, Ogawa Y, et al. Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen[J]. Int Med, 2002, 41: 345-350.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部